Vicente Peg

11PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 06, 2026
Evaluating total tumor load (TTL) to predict metastasis in four or more axillary lymph nodes in HR +/HER2- breast cancer patients: the TULIP4N + study.

|Dec 05, 2024
New Approach in the Interpretation of Complex Triple-negative Breast Cancer Immunohistochemistry Specimens Processed With VENTANA PD-L1 (SP142) Assay.

Vicente Peg, Marta Abengozar-Muela, Jesús Acosta

|Sep 13, 2023
Early-Stage Breast Cancer Detection in Breast Milk.

Cristina Saura, Carolina Ortiz, Judit Matito

|Dec 08, 2022
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response.

Nikaoly Ciriaco, Esther Zamora, Santiago Escrivá-de-Romaní

|Apr 15, 2022
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.

Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara

|Dec 08, 2020
PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion.

Vicente Peg, María Ángeles López-García, Laura Comerma

Pageof 2

Frequent Collaborators

3 joint publications

Joaquín Arribas

3 joint publications

Paolo Nuciforo

2 joint publications

Santiago Ramon Y Cajal

2 joint publications

Martín Espinosa-Bravo